Krisztus Temető Szemléltet acid alpha glucosidase Gabona hősies meteor
Inhibitory effects of pu-erh tea on alpha glucosidase and alpha amylase: a systemic review | Nutrition & Diabetes
Glycoengineered Acid α-Glucosidase With Improved Efficacy at Correcting the Metabolic Aberrations and Motor Function Deficits in a Mouse Model of Pompe Disease: Molecular Therapy
Acid alpha-glucosidase or acid maltase, is an enzyme that helps to break down glycogen in the lysosome. 3d illustration Stock Photo - Alamy
Acid alpha-glucosidase or acid maltase, is an enzyme that helps to break down glycogen in the lysosome. 3d illustration Stock Photo - Alamy
About Pompe Disease - United Pompe Foundation
Endolysosomal N-glycan processing is critical to attain the most active form of the enzyme acid alpha-glucosidase - ScienceDirect
Cell type-selective targeted delivery of a recombinant lysosomal enzyme for enzyme therapies: Molecular Therapy
Biomolecules | Free Full-Text | Alpha-Amylase and Alpha-Glucosidase Enzyme Inhibition and Antioxidant Potential of 3-Oxolupenal and Katononic Acid Isolated from Nuxia oppositifolia
Antioxidants | Free Full-Text | Alpha-Glucosidase and Alpha-Amylase Inhibitory Activities, Molecular Docking, and Antioxidant Capacities of Salvia aurita Constituents
IJTM | Free Full-Text | The Action of Recombinant Human Lysosomal α- Glucosidase (rhGAA) on Human Liver Glycogen: Pathway to Complete Degradation
Mechanism of action of alpha-glucosidase inhibitors. | Download Scientific Diagram
Structure of human lysosomal acid α-glucosidase–a guide for the treatment of Pompe disease | Nature Communications
PDF) Structure of human lysosomal acid α-glucosidase-A guide for the treatment of Pompe disease
Acid alpha-glucosidase - Wikipedia
Figure 6, Capacity of inhibitors to maintain the function of acid alpha glucosidase after incubation at 66°C for 60 minutes - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf
Schematic drawing of consequences of α-glucosidase deficiency and ERT... | Download Scientific Diagram
Consensus treatment recommendations for lateonset Pompe disease